Table 4.
Summary outcomes: relative and absolute effects on antibiotic prescriptions
| ATB prescribed | Effect | ||||
|---|---|---|---|---|---|
| Intervention n/N (%) |
Control n/N (%) |
Relative Risk Reduction [95%CI] |
Absolute (Risk Difference) [95%CI] |
Numbers needed to test to prevent one more antibiotic prescription [95%CI] |
|
| Overall | 183/551 (33.2) | 318/547 (58.1) | 42.9% reduction [from 34.4 to 50.2] | 25 fewer ATB prescriptions per 100 (from 19 to 31) | 1 fewer ATB prescription every 4 patients tested (from 5 to 3) |
| Respiratory | 79/189 (41.8) | 206/227 (90.7) | 53.9% reduction [from 45.2 to 61.3] | 49 fewer ATB prescriptions per 100 (from 41 to 57) | 1 fewer ATB prescription every 2 patients tested (from 2 to 2) |
| Malaria negative | 111/264 (42) | 233/262 (88.9% | 52.7% reduction [from 45.2 to 59.2] | 47 fewer ATB prescriptions per 100 (from 40 to 54) | 1 fewer ATB prescription every 2 patients tested (from 3 to 2) |
| Age under 5 years | 109/327 (33.3) | 219/323 (67.8) | 50.8% reduction [from 41.7 to 58.6] | 34 fewer ATB prescriptions per 100 (from 27 to 42) | 1 fewer ATB prescription every 3 patients tested (from 4 to 2) |
| Age over 18 years | 10/35 (28.6) | 20/31 (64.5) |
55.7% reduction (from 20.5 to 75.3) |
35.9 fewer ATB prescriptions per 100 (from 13.4 to 58.5%) |
1 fewer ATB prescription every 3 patients tested (from 7 to 2)) |